Siegfried Holding AG

SFZN

Company Profile

  • Business description

    Siegfried is a global contract development and manufacturing organization. It derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. The company provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 16 production sites on four continents.

  • Contact

    Untere Bruehlstrasse 4
    ZofingenCH-4800
    CHE

    T: +41 627461111

    E: [email protected]

    https://www.siegfried.ch

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    4,454

Stocks News & Analysis

stocks

5 star fully franked ASX dividend payer

Investors in cheap ASX share with a narrow moat enjoys a high yield, but there are risks investors should be aware of.
stocks

An undervalued stock to buy that even Warren Buffett likes

Trading at an 18% discount, this wide-moat stock is a rare find.
stocks

ASX REIT downgraded following underwhelming exit

Discounted exit raises investor concerns.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,886.6035.900.41%
CAC 408,082.604.120.05%
DAX 4025,435.2060.780.24%
Dow JONES (US)51,481.51347.11-0.67%
FTSE 10010,704.7719.890.19%
HKSE24,523.57118.94-0.48%
NASDAQ26,820.38248.34-0.92%
Nikkei 22565,481.27396.35-0.60%
NZX 50 Index13,683.63147.05-1.06%
S&P 5007,683.6959.72-0.77%
S&P/ASX 2008,709.3029.600.34%
SSE Composite Index3,830.456.830.18%

Market Movers